Proal, A. D. & VanElzakker, M. B. Lengthy COVID or post-acute sequelae of COVID-19 (PASC): an outline of organic elements that will contribute to persistent signs. Entrance. Microbiol. https://doi.org/10.3389/FMICB.2021.698169 (2021).
Nationwide Middle for Well being Statistics. US Census Bureau, Family Pulse Survey, 2022–2023. Lengthy COVID (2023).
Cutler, D. M. The financial value of lengthy COVID: an replace (2023). White Paper. https://scholar.harvard.edu/recordsdata/cutler/recordsdata/long_covid_update_7-22.pdf (2023).
Davis, H. E., McCorkell, L., Vogel, J. M. & Topol, E. J. Lengthy COVID: main findings, mechanisms and proposals. Nat. Rev. Microbiol. https://doi.org/10.1038/S41579-022-00846-2 (2023).
Davis, H. E. et al. Characterizing lengthy COVID in a world cohort: 7 months of signs and their influence. EClinicalMedicine https://doi.org/10.1016/J.ECLINM.2021.101019 (2021).
Petersen, E. L. et al. Multi-organ evaluation in primarily non-hospitalized people after SARS-CoV-2 an infection: the Hamburg Metropolis Well being Examine COVID programme. Eur. Coronary heart J. 43, 1124–1137 (2022).
Peluso, M. J. et al. Persistence, magnitude, and patterns of postacute signs and high quality of life following onset of SARS-CoV-2 an infection: cohort description and approaches for measurement. Open Discussion board Infect. Dis. https://doi.org/10.1093/OFID/OFAB640 (2022).
Lopez-Leon, S. et al. Lengthy-COVID in youngsters and adolescents: a scientific overview and meta-analyses. Sci. Rep. https://doi.org/10.1038/S41598-022-13495-5 (2022).
Funk, A. L. et al. Publish–COVID-19 situations amongst youngsters 90 days after SARS-CoV-2 an infection. JAMA Netw. Open. 5, E2223253 (2022).
Facilities for Illness Management and Prevention. Well being department-reported instances of multisystem inflammatory syndrome in youngsters (MIS-C) in the US. https://www.cdc.gov/mis/index.html (2023).
Keita, A. Okay. et al. A 40-month follow-up of Ebola virus illness survivors in Guinea (Postebogui) reveals long-term detection of Ebola viral ribonucleic acid in semen and breast milk. Open Discussion board Infect. Dis. https://doi.org/10.1093/ofid/ofz482 (2019).
Varkey, J. B. et al. Persistence of Ebola virus in ocular fluid throughout convalescence. N. Engl. J. Med. 372, 2423–2427 (2015).
Sow, M. S. et al. New proof of long-lasting persistence of Ebola virus genetic materials in semen of survivors. J. Infect. Dis. 214, 1475–1476 (2016).
Paz-Bailey, G. et al. Persistence of Zika virus in physique fluids—last report. N. Engl. J. Med. 379, 1234–1243 (2018).
Chia, J. Okay. S. & Chia, A. Y. Persistent fatigue syndrome is related to power enterovirus an infection of the abdomen. J. Clin. Pathol. 61, 43–48 (2008).
Kühl, U. et al. Viral persistence within the myocardium is related to progressive cardiac dysfunction. Circulation 112, 1965–1970 (2005).
Permar, S. R. et al. Extended measles virus shedding in human immunodeficiency virus-infected youngsters, detected by reverse transcriptase-polymerase chain response. J. Infect. Dis. 183, 532–538 (2001).
Riddell, M. A., Moss, W. J., Hauer, D., Monze, M. & Griffin, D. E. Sluggish clearance of measles virus RNA after acute an infection. J. Clin. Virol. 39, 312–317 (2007).
Dokubo, E. Okay. et al. Persistence of Ebola virus after the tip of widespread transmission in Liberia: an outbreak report. Lancet Infect. Dis. 18, 1015–1024 (2018).
Scott, J. T. et al. Publish-Ebola syndrome, Sierra Leone. Emerg. Infect. Dis. 22, 641–646 (2016).
Subissi, L. et al. Ebola virus transmission brought on by persistently contaminated survivors of the 2014-2016 outbreak in West Africa. J. Infect. Dis. 218, S287–S291 (2018).
Keita, A. Okay. et al. Resurgence of Ebola virus in 2021 in Guinea suggests a brand new paradigm for outbreaks. Nature 597, 539–543 (2021).
Russell, Okay. et al. Male-to-Feminine sexual transmission of Zika virus—United States, January–April 2016. Clin. Infect. Dis. 64, 211–213 (2017).
Peluso, M. J. et al. Multimodal molecular imaging reveals tissue-based T cell activation and viral RNA persistence for as much as 2 years following COVID-19. Preprint at medRxiv https://doi.org/10.1101/2023.07.27.23293177 (2023).
Yao, Q. et al. Lengthy-term dysfunction of style papillae in SARS-CoV-2. NEJM Proof. https://doi.org/10.1056/EVIDoa2300046 (2023).
Rendeiro, A. F. et al. Persistent alveolar kind 2 dysfunction and lung structural derangement in post-acute COVID-19. Preprint at medRxiv https://doi.org/10.1101/2022.11.28.22282811 (2022).
de Melo, G. D. et al. COVID-19-related anosmia is related to viral persistence and irritation in human olfactory epithelium and mind an infection in hamsters. Sci. Transl. Med. https://doi.org/10.1126/SCITRANSLMED.ABF8396 (2021).
Cheung, C. C. L. et al. Residual SARS-CoV-2 viral antigens detected in GI and hepatic tissues from 5 recovered sufferers with COVID-19. Intestine https://doi.org/10.1136/gutjnl-2021-324280 (2021).
Hany, M. et al. Lingering SARS-CoV-2 in gastric and gallbladder tissues of sufferers with earlier COVID-19 an infection present process bariatric surgical procedure. Obes. Surg. 33, 139–148 (2022).
Miura, C. S. et al. Asymptomatic SARS-COV-2 an infection in youngsters’s tonsils. Braz. J. Otorhinolaryngol. 88, 9 (2022).
Stein, S. R. et al. SARS-CoV-2 an infection and persistence within the human physique and mind at post-mortem. Nature 612, 758–763 (2022).
Roden, A. C. et al. Late issues of COVID-19: a morphologic, imaging, and droplet digital polymerase chain response research of lung tissue. Arch. Pathol. Lab. Med. https://doi.org/10.5858/arpa.2021-0519-sa (2022).
Gaebler, C. et al. Evolution of antibody immunity to SARS-CoV-2. Nature 591, 639–644 (2021).
Support, M. et al. Zika virus persistence within the central nervous system and lymph nodes of rhesus monkeys. Cell 169, 610–620 (2017).
Mead, P. S. et al. Zika virus shedding in semen of symptomatic contaminated males. N. Engl. J. Med. 378, 1377–1385 (2018).
Coffin, Okay. M. et al. Persistent Marburg virus an infection within the testes of nonhuman primate survivors. Cell Host Microbe 24, 405–416 (2018).
Xu, Q. et al. Adaptive immune responses to SARS-CoV-2 persist within the pharyngeal lymphoid tissue of youngsters. Nat. Immunol. 24, 186–199 (2022).
Zollner, A. et al. Postacute COVID-19 is characterised by intestine viral antigen persistence in inflammatory bowel ailments. Gastroenterology 163, 495–506 (2022).
Goh, D. et al. Case report: persistence of residual antigen and RNA of the SARS-CoV-2 virus in tissues of two sufferers with lengthy COVID. Entrance Immunol. 13, 939989 (2022).
Schultheiß, C. et al. Liquid biomarkers of macrophage dysregulation and circulating spike protein 1 illustrate the organic heterogeneity in sufferers with post-acute sequelae of COVID-19. J. Med. Virol. https://doi.org/10.1002/jmv.28364 (2023).
Swank, Z. et al. Persistent circulating SARS-CoV-2 spike is related to post-acute COVID-19 sequelae. Clin. Infect. Dis. https://doi.org/10.1093/CID/CIAC722 (2022).
Peluso, M. et al. Plasma-based antigen persistence within the post-acute section of SARS-CoV-2 an infection. Poster presentation. https://www.croiconference.org/summary/plasma-based-antigen-persistence-in-the-post-acute-phase-of-sars-cov-2-infection/ (2023).
Ogata, A. F. et al. Circulating extreme acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine antigen detected within the plasma of mRNA-1273 vaccine recipients. Clin. Infect. Dis. 74, 715–718 (2022).
Peluso, M. J. et al. SARS-CoV-2 and mitochondrial proteins in neural-derived exosomes of COVID-19. Ann. Neurol. 91, 772–781 (2022).
Craddock, V. et al. Persistent circulation of soluble and extracellular vesicle-linked Spike protein in people with postacute sequelae of COVID-19. J. Med. Virol. https://doi.org/10.1002/JMV.28568 (2023).
Adaken, C. et al. Ebola virus antibody decay–stimulation in a excessive proportion of survivors. Nature 590, 468–472 (2021).
Nelson, A. N. et al. Evolution of T cell responses throughout measles virus an infection and RNA clearance. Sci. Rep. 7, 11474 (2017).
Herati, R. S. et al. PD-1 directed immunotherapy alters Tfh and humoral immune responses to seasonal influenza vaccine. Nat. Immunol. 23, 1183–1192 (2022).
Herati, R. S. et al. Vaccine-induced ICOS+CD38+ circulating Tfh are delicate biosensors of age-related modifications in inflammatory pathways. Cell Rep. Med. https://doi.org/10.1016/J.XCRM.2021.100262 (2021).
Sykulev, Y., Joo, M., Vturina, I., Tsomides, T. J. & Eisen, H. N. Proof {that a} single peptide-MHC complicated on a goal cell can elicit a cytolytic T cell response. Immunity 4, 565–571 (1996).
Wherry, E. J., Blattman, J. N., Murali-Krishna, Okay., van der Most, R. & Ahmed, R. Viral persistence alters CD8 T-cell immunodominance and tissue distribution and ends in distinct levels of useful impairment. J. Virol. 77, 4911–4927 (2003).
Appay, V. et al. Reminiscence CD8+ T cells range in differentiation phenotype in several persistent virus infections. Nat. Med. 8, 379–385 (2002).
Purbhoo, M. A., Irvine, D. J., Huppa, J. B. & Davis, M. M. T cell killing doesn’t require the formation of a steady mature immunological synapse. Nat. Immunol. 5, 524–530 (2004).
Vibholm, L. Okay. et al. SARS-CoV-2 persistence is related to antigen-specific CD8 T-cell responses. EBioMedicine https://doi.org/10.1016/j.ebiom.2021.103230 (2021).
Peluso, M. J. et al. Lengthy-term SARS-CoV-2-specific immune and inflammatory responses in people recovering from COVID-19 with and with out post-acute signs. Cell Rep. https://doi.org/10.1016/J.CELREP.2021.109518 (2021).
Littlefield, Okay. M. et al. SARS-CoV-2-specific T cells affiliate with irritation and diminished lung perform in pulmonary post-acute sequalae of SARS-CoV-2. PLoS Pathog. 18, e1010359 (2022).
Visvabharathy, L. et al. T cell responses to SARS-CoV-2 in individuals with and with out neurologic signs of lengthy COVID. Preprint at medRxiv https://doi.org/10.1101/2021.08.08.21261763 (2022).
Yin, Okay. et al. Lengthy COVID manifests with T cell dysregulation, irritation, and an uncoordinated adaptive immune response to SARS-CoV-2. Preprint at bioRxiv https://doi.org/10.1101/2023.02.09.527892 (2023).
Klein, J. et al. Distinguishing options of Lengthy COVID recognized by means of immune profiling. Preprint at medRxiv https://doi.org/10.1101/2022.08.09.22278592 (2022).
Santa Cruz, A. et al. Publish-acute sequelae of COVID-19 is characterised by diminished peripheral CD8+ β7 integrin+ T cells and anti-SARS-CoV-2 IgA response. Nat. Commun. 14, 1772 (2023).
Metcalf, T. U. & Griffin, D. E. Alphavirus-induced encephalomyelitis: antibody-secreting cells and viral clearance from the nervous system. J. Virol. 85, 11490–11501 (2011).
Metcalf, T. U., Baxter, V. Okay., Nilaratanakul, V. & Griffin, D. E. Recruitment and retention of B cells within the central nervous system in response to alphavirus encephalomyelitis. J. Virol. 87, 2420–2429 (2013).
Nelson, A. N. et al. Affiliation of persistent wild-type measles virus RNA with long-term humoral immunity in rhesus macaques. JCI Perception https://doi.org/10.1172/JCI.INSIGHT.134992 (2020).
Yewdell, W. T. et al. Temporal dynamics of persistent germinal facilities and reminiscence B cell differentiation following respiratory virus an infection. Cell Rep. 37, 109961 (2021).
Kim, T. S., Hufford, M. M., Solar, J., Fu, Y. X. & Braciale, T. J. Antigen persistence and the management of native T cell reminiscence by migrant respiratory dendritic cells after acute virus an infection. J. Exp. Med. 207, 1161–1172 (2010).
de Carvalho, R. V. H. et al. Clonal alternative sustains long-lived germinal facilities primed by respiratory viruses. Cell 186, 131–146 (2023).
Rashid, F. et al. Roles and capabilities of SARS-CoV-2 proteins in host immune evasion. Entrance. Immunol. https://doi.org/10.3389/FIMMU.2022.940756 (2022).
Kee, J. et al. SARS-CoV-2 disrupts host epigenetic regulation by way of histone mimicry. Nature 610, 381–388 (2022).
Pretorius, E. et al. Persistent clotting protein pathology in Lengthy COVID/post-acute sequelae of COVID-19 (PASC) is accompanied by elevated ranges of antiplasmin. Cardiovasc. Diabetol. https://doi.org/10.1186/s12933-021-01359-7 (2021).
Grobbelaar, L. M. et al. SARS-CoV-2 spike protein S1 induces fibrin(ogen) immune to fibrinolysis: implications for microclot formation in COVID-19. Biosci. Rep. https://doi.org/10.1042/BSR20210611 (2021).
Ryu, J. Okay. et al. SARS-CoV-2 spike protein induces irregular inflammatory blood clots neutralized by fibrin immunotherapy. Preprint at bioRxiv https://doi.org/10.1101/2021.10.12.464152 (2021).
De Michele, M. et al. Proof of SARS-CoV-2 spike protein on retrieved thrombi from COVID-19 sufferers. J. Hematol. Oncol. 15, 108 (2022).
Boribong, B. P. et al. Neutrophil profiles of pediatric COVID-19 and multisystem inflammatory syndrome in youngsters. Cell Rep. Med. https://doi.org/10.1016/J.XCRM.2022.100848 (2022).
Cervia, C. et al. Immunoglobulin signature predicts threat of post-acute COVID-19 syndrome. Nat Commun. https://doi.org/10.1038/S41467-021-27797-1 (2022).
Hadjadj, J. et al. Impaired kind I interferon exercise and inflammatory responses in extreme COVID-19 sufferers. Science 369, 718–724 (2020).
Gold, J. E., Okyay, R. A., Licht, W. E. & Hurley, D. J. Investigation of lengthy COVID prevalence and its relationship to Epstein–Barr virus reactivation. Pathogens https://doi.org/10.3390/PATHOGENS10060763 (2021).
Peluso, M. J. et al. Affect of pre-existing power viral an infection and reactivation on the event of lengthy COVID. J. Clin. Make investments. https://doi.org/10.1172/JCI163669 (2022).
Su, Y. et al. A number of early elements anticipate post-acute COVID-19 sequelae. Cell https://doi.org/10.1016/j.cell.2022.01.014 (2022).
Gu, L. et al. Dynamic modifications within the microbiome and mucosal immune microenvironment of the decrease respiratory tract by influenza virus an infection. Entrance Microbiol. https://doi.org/10.3389/FMICB.2019.02491 (2019).
Kaul, D. et al. Microbiome disturbance and resilience dynamics of the higher respiratory tract throughout influenza A virus an infection. Nat Commun. https://doi.org/10.1038/s41467-020-16429-9 (2020).
Eastment, M. C. & McClelland, R. S. Vaginal microbiota and susceptibility to HIV. AIDS 32, 687–698 (2018).
Liu, Q. et al. Intestine microbiota dynamics in a potential cohort of sufferers with post-acute COVID-19 syndrome. Intestine 71, 544–552 (2022).
Giron, L. B. et al. Markers of fungal translocation are elevated throughout post-acute sequelae of SARS-CoV-2 and induce NF-κB signaling. JCI Perception https://doi.org/10.1172/JCI.INSIGHT.160989 (2022).
Yonker, L. M. et al. Multisystem inflammatory syndrome in youngsters is pushed by zonulin-dependent lack of intestine mucosal barrier. J. Clin. Make investments. https://doi.org/10.1172/JCI149633 (2021).
Wang, W., Uzzau, S., Goldblum, S. E. & Fasano, A. Human zonulin, a possible modulator of intestinal tight junctions. J. Cell Sci. https://doi.org/10.1242/jcs.113.24.4435 (2000).
Fasano, A. et al. Zonulin, a newly found modulator of intestinal permeability, and its expression in coeliac illness. Lancet https://doi.org/10.1016/S0140-6736(00)02169-3 (2000).
Malik, A. et al. Distorted TCR repertoires outline multisystem inflammatory syndrome in youngsters. PLoS ONE 17, e0274289 (2022).
Kreye, J., Reincke, S. M. & Prüss, H. Do cross-reactive antibodies trigger neuropathology in COVID-19. Nat. Rev. Immunol. 20, 645–646 (2020).
Lanz, T. V. et al. Clonally expanded B cells in a number of sclerosis bind EBV EBNA1 and GlialCAM. Nature 603, 321–327 (2022).
McCusker, R. H. & Kelley, Okay. W. Immune–neural connections: how the immune system’s response to infectious brokers influences conduct. J. Exp. Biol. 216, 84–98 (2013).
Goehler, L. E. et al. Activation in vagal afferents and central autonomic pathways: early responses to intestinal an infection with Campylobacter jejuni. Mind Behav. Immun. 19, 334–344 (2005).
VanElzakker, M. B. Persistent fatigue syndrome from vagus nerve an infection: a psychoneuroimmunological speculation. Med. Hypotheses 81, 414–423 (2013).
Woo, M. S. et al. Vagus nerve irritation contributes to dysautonomia in COVID-19. Acta Neuropathol. 146, 387–394 (2023).
Matschke, J. et al. Neuropathology of sufferers with COVID-19 in Germany: a autopsy case sequence. Lancet Neurol. 19, 919–929 (2020).
Track, E. et al. Neuroinvasion of SARS-CoV-2 in human and mouse mind. J. Exp. Med. https://doi.org/10.1084/JEM.20202135 (2021).
Wang, L. et al. Affiliation of COVID-19 with new-onset Alzheimer’s illness. J. Alzheimers Dis. 89, 411–414 (2022).
Rhodes, C. H., Priemer, D. S., Karlovich, E., Perl, D. P. & Goldman, J. β-amyloid deposits in younger COVID sufferers. SSRN Digital Journal https://doi.org/10.2139/SSRN.4003213 (2022).
Soscia, S. J. et al. The Alzheimer’s disease-associated amyloid β-protein is an antimicrobial peptide. PLoS ONE https://doi.org/10.1371/JOURNAL.PONE.0009505 (2010).
Eimer, W. A. et al. Alzheimer’s disease-associated β-amyloid is quickly seeded by herpesviridae to guard towards mind an infection. Neuron 99, 56–63 (2018).
Kumar, D. Okay. V. et al. Amyloid-β peptide protects towards microbial an infection in mouse and worm fashions of Alzheimer’s illness. Sci. Transl. Med. 8, 340ra72 (2016).
Aung, A. et al. Low protease exercise in B cell follicles promotes retention of intact antigens after immunization. Science https://doi.org/10.1126/SCIENCE.ABN8934/SUPPL_FILE/SCIENCE.ABN8934_MDAR_REPRODUCIBILITY_CHECKLIST.PDF (2023).
Griffin, D. E. Why does viral RNA generally persist after restoration from acute infections? PLoS Biol. 20, e3001687 (2022).
Emmler, L. et al. Feline coronavirus with and with out spike gene mutations detected by real-time RT–PCRs in cats with feline infectious peritonitis. J. Feline Med. Surg. 22, 791–799 (2020).
Arshad, N. et al. SARS-CoV-2 accent proteins ORF7a and ORF3a use distinct mechanisms to down-regulate MHC-I floor expression. Proc. Natl Acad. Sci. 120, e2208525120120 (2023).
Moriyama, M., Lucas, C., Monteiro, V. S., Yale SARS-CoV-2 Genomic Surveillance Initiative & Iwasaki, A. SARS-CoV-2 Omicron subvariants advanced to advertise additional escape from MHC-I recognition. Preprint at bioRxiv https://doi.org/10.1101/2022.05.04.490614 (2022).
Peluso, M. J. et al. Impact of oral nirmatrelvir on Lengthy COVID signs: a case sequence. https://doi.org/10.21203/RS.3.RS-1617822/V2 (2022).
Geng, L. N., Bonilla, H. F., Shafer, R. W., Miglis, M. G., Yang, P. C. Case report of breakthrough lengthy COVID and the usage of nirmatrelvir-ritonavir. Preprint at Analysis Sq. https://doi.org/10.21203/rs.3.rs-1443341/v1 (2022).
Schultz, D. C. et al. Pyrimidine inhibitors synergize with nucleoside analogues to dam SARS-CoV-2. Nature 604, 134–140 (2022).
Xie, Y., Choi, T. & Al-Aly Z. Nirmatrelvir and the danger of post-acute sequelae of COVID-19. Preprint at medRxiv https://doi.org/10.1101/2022.11.03.22281783 (2022).
Yonker, L. M. et al. Zonulin antagonist, Larazotide (AT1001), as an adjuvant therapy for multisystem inflammatory syndrome in youngsters: a case sequence. Crit. Care Explor. 4, e0641 (2022).
Proal, A. & Marshall, T. Myalgic encephalomyelitis/power fatigue syndrome within the period of the human microbiome: persistent pathogens drive power signs by interfering with host metabolism, gene expression, and immunity. Entrance. Pediatr. https://doi.org/10.3389/fped.2018.00373 (2018).
Bjornevik, Okay. et al. Longitudinal evaluation reveals excessive prevalence of Epstein–Barr virus related to a number of sclerosis. Science 375, 296–301 (2022).
Harley, J. B. et al. Transcription elements function throughout illness loci, with EBNA2 implicated in autoimmunity. Nat. Genet. 50, 699–707 (2018).
Cheung, C. C. L. et al. Residual SARS-CoV-2 viral antigens detected in GI and hepatic tissues from 5 recovered sufferers with COVID-19. Intestine 71, 226–229 (2022).
Natarajan, A. et al. Gastrointestinal signs and fecal shedding of SARS-CoV-2 RNA recommend extended gastrointestinal an infection. Med. 3, 371–387 (2022).
Jin, J. C. et al. SARS-CoV-2 detected in neonatal stool distant from maternal COVID-19 throughout being pregnant. Pediatr. Res. https://doi.org/10.1038/s41390-022-02266-7 (2022).
Tejerina, F. et al. Publish-COVID-19 syndrome. SARS-CoV-2 RNA detection in plasma, stool, and urine in sufferers with persistent signs after COVID-19. BMC Infect. Dis. 22, 211 (2022).
